FDA remains committed to taking enforcement actions against unapproved drugs in an effort to ensure that drugs used by patients are safe and effective, while at the same time ensuring that such actions do not impose an undue burden on patients. Currently, there are no approved morphine sulfate oral solution 20 mg/ml products being marketed in the U.S. FDA has heard from the pain management community that the impending market removal of unapproved morphine sulfate oral solution 20 mg/ml products announced in the Warning Letters would impose unacceptable hardship on palliative care patients, their families and caregivers. In light of this information, FDA will extend the enforcement discretion set forth in the Warning Letters to ensure that palliative care patients have access to morphine sulfate oral solution 20 mg/ml. The period of enforcement discretion will be extended until 180 days after any firm receives approval for a morphine sulfate oral solution 20 mg/ml product or if FDA determines that alternative medications become available for the palliative care patient.
Search
About
You are currently browsing the Southwest Michigan Pharmacists Association weblog archives for the month April, 2009.
Latest
RSS- CALMING AN OVERACTIVE BRAIN
- CALMING AN OVERACTIVE BRAIN
- REDUCTION IN THE RISK OF STROKE AND OTHER MAJOR CV EVENTS
- A NEW ERA IN CARDIOVASCULAR CARE
- 345
- REASONING WITH UNREASONABLE PEOPLE
- 335
- 6 HOURS OF LIVE CEU ON BRAIN HEALTH
- SWMPA DINNER/LECTURE MEETING OCT. 15, 2018
- INHALER CHOICE MATTERS IN COPD–IMPACT OF PEAK INSPIRATORY FLOW ON DRUG DISPERSION AND DELIVERY FROM INHALERS
Archives
- March 2020
- February 2020
- September 2019
- February 2019
- October 2018
- September 2018
- July 2018
- May 2018
- April 2018
- March 2018
- October 2017
- September 2017
- July 2017
- June 2017
- February 2017
- October 2016
- September 2016
- August 2016
- March 2016
- February 2016
- January 2016
- August 2015
- May 2015
- April 2015
- March 2015
- January 2015
- November 2014
- July 2014
- March 2014
- February 2014
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- April 2013
- February 2013
- January 2013
- December 2012
- November 2012
- May 2011
- February 2011
- November 2010
- August 2010
- June 2010
- April 2010
- March 2010
- February 2010
- January 2010
- November 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
Categories
- ACE (1)
- Drug Shortages (1)
- Education (32)
- General (77)
- Medicare and Medicaid (2)
- Meeting Information (26)
- New Drug Approvals (11)
- Pharmacy Law (1)
- video (1)